CALCIUM ANTAGONISTIC EFFECTS AND THE INVITRO DURATION OF ACTIONS OF KW-3049, A NEW 1,4-DIHYDROPYRIDINE DERIVATIVE, IN ISOLATED CANINE CORONARY-ARTERIES

被引：66

作者：

KARASAWA, A

KUBO, K

机构：

来源：

JAPANESE JOURNAL OF PHARMACOLOGY | 1988年 / 47卷 / 01期

关键词：

D O I：

10.1254/jjp.47.35

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：35 / 44

页数：10

共 30 条

[1]

AOKI K, 1978, AM HEART J, V96, P219

[2]

BURGES R A, 1985, British Journal of Pharmacology, V85, p281P

[3] MECHANISMS OF CALCIUM ANTAGONIST-INDUCED VASODILATION [J].

CAUVIN, C ;

LOUTZENHISER, R ;

VANBREEMEN, C .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 :373-396

[4] CALCIUM ANTAGONISTIC DRUGS - MECHANISM OF ACTION [J].

CHURCH, J ;

ZSOTER, TT .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1980, 58 (03) :254-264

[5] THERAPEUTIC IMPLICATIONS OF SLOW-CHANNEL BLOCKADE IN CARDIOCIRCULATORY DISORDERS [J].

ELLRODT, G ;

CHEW, CYC ;

SINGH, BN .

CIRCULATION, 1980, 62 (04) :669-679

[6] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[7]

GODFRAIND T, 1981, FED PROC, V40, P2866

[8]

HASHIMOTO K, 1972, ARZNEI-FORSCHUNG, V22, P15

[9] EFFECTS OF THE CALCIUM-ANTAGONIST PY-108-068 ON MYOCARDIAL TISSUES INVITRO AND ON REFLEX TACHYCARDIA INVIVO [J].

HOF, RP ;

SCHOLTYSIK, G .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (02) :176-183

[10] PN-200-110, A NEW CALCIUM-ANTAGONIST - ELECTROPHYSIOLOGICAL, INOTROPIC, AND CHRONOTROPIC EFFECTS ON GUINEA-PIG MYOCARDIAL TISSUE AND EFFECTS ON CONTRACTION AND CALCIUM-UPTAKE OF RABBIT AORTA [J].

HOF, RP ;

SCHOLTYSIK, G ;

LOUTZENHISER, R ;

VUORELA, HJ ;

NEUMANN, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) :399-406

← 1 2 3 →